secwatch.observer — SEC 8-K summary
======================================

Issuer:     Lyra Therapeutics, Inc. (LYRA)
CIK:        0001327273
Form:       8-K
Filed at:   2023-12-28T23:59:59+00:00
Accession:  0000950170-23-073432
Event type: other_material
Sentiment:  neutral
Materiality: 0.45
Item codes: 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Lyra Therapeutics subleases ~23,704 sq ft lab/office in Waltham, MA
-------------------------------------------------------------------

- Sublease with RVAC Medicines for 23,704 sq ft at 880 Winter Street, Waltham, MA.
- Term expected to start Jan 1, 2024; expires Nov 30, 2032.
- Monthly base rent $150,125.33 (~$1.8M annual); 3% annual escalator; first two months rent-free.
- Requires $450,375.99 letter of credit as security deposit; also pays share of operating expenses, utilities, taxes.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1327273/000095017023073432/0000950170-23-073432-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1327273/000095017023073432/lyra-20231221.htm
  HTML page:      https://secwatch.observer/filing/0000950170-23-073432

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer